TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Microbiotech/se AB
Closing information (x1000 NOK)
| Closing information | 2024/04 | 2023/04 | 2022/04 |
| Turnover |
3,123
|
2,757
|
3,047 |
| Financial expenses |
0
|
1
|
0 |
| Earnings before taxes |
248
|
23
|
-59 |
| EBITDA |
237
|
24
|
-59 |
| Total assets |
2,300
|
2,324
|
2,417 |
| Current assets |
2,300
|
2,324
|
2,417 |
| Current liabilities |
270
|
414
|
659 |
| Equity capital |
1,948
|
1,811
|
1,652 |
| - share capital |
332
|
342
|
315 |
| Employees (average) |
4
|
3
|
4 |
Financial ratios
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Solvency |
84.7%
|
77.9%
|
68.3% |
| Turnover per employee |
781
|
919
|
762 |
| Profit as a percentage of turnover |
7.9%
|
0.8%
|
-1.9% |
| Return on assets (ROA) |
10.8%
|
1.0%
|
-2.4% |
| Current ratio |
851.9%
|
561.4%
|
366.8% |
| Return on equity (ROE) |
12.7%
|
1.3%
|
-3.6% |
| Change turnover |
450
|
-556
|
625 |
| Change turnover % |
17%
|
-17%
|
26% |
| Chg. No. of employees |
1
|
-1
|
4 |
| Chg. No. of employees % |
33%
|
-25% |
Total value of public sale
| Fiscal year | 2024/04 | 2023/04 | 2022/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.